ITTM’s innovative co-founder Dr. Andreas Kremer reveals the steps his start-up is currently undertaking to restructure the world of BioIT and the presentation of medical information.
Why did you personally decide a year and half ago that ITTM was going to be your next adventure, and what were your first impressions of Luxembourg’s Life Sciences scene?
“People always try to put you in existing boxes but the definition of new does not include existing boxes, you need a new box.”
Philippe Sollie reveals the inspirations behind Flen Pharma and how approaching dermatology from a pharmaceutical background has proved beneficial in building an innovative and competitive enterprise. When you founded Flen…
Novartis’ newest Head for the Grand-Duchy of Luxembourg provides a fascinating insight into the Luxembourg market and reveals how this small nation has found itself in pole position for future…
Miriam Steimer, as employee number one of the Fast-track diagnostics success story, provides a thorough analysis into the company’s global footprint, the scope of operations in Luxembourg with both manufacturing…
Drawing on the findings of the Business Ethics for APEC SMEs Initiative, Thomas Cueni of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) outlines the benefits for small and…
Bernie Zeiher, chief medical officer (CMO) of Astellas explains why the ‘patient-defined value’ of medicines is crucial to developing therapies that truly address patients’ unmet medical needs. Zeiher outlines some…
Over two years since the first cases of COVID-19, the world is still coming to terms with the virus. While vaccines have been developed and rolled out in record time…
See our Cookie Privacy Policy Here